Skip to main content

Want a detailed portfolio tracker?

OverviewPerformanceMetricsFinancialsETFsIndustryCorrelations

SBC Medical Group (SBC) Income Statement (2022 - 2026)

Income Statement report data from Mar 31, 2022 to Mar 31, 2026 for SBC Medical Group (SBC).

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Reported currency: USD
Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Jun 30, 2022Mar 31, 2022
Revenue and COGS
Total Revenue
43M
(+8.82%)
40M
(-8.72%)
43M
(-0.02%)
43M
(-8.39%)
47M
(+6.55%)
44M
(-16.31%)
53M
(-0.04%)
53M
(-3.12%)
55M
(-62.53%)
146M
(+209.35%)
47M----
Cost Of Revenue
13M
(+19.45%)
11M
(-16.48%)
13M
(-4.57%)
13M
(+39.06%)
9.60M
(-9.00%)
11M
(+7.11%)
9.85M
(-28.00%)
14M
(-10.53%)
15M
(-63.99%)
42M
(+208.13%)
14M----
Costof Goods And Services Sold
13M
(+19.45%)
11M
(-16.48%)
13M
(-4.57%)
13M
(+39.06%)
9.60M
(-9.00%)
11M
(+7.11%)
9.85M
(-28.00%)
14M
(-10.53%)
15M
(-63.99%)
42M
(+208.13%)
14M----
Gross Profit
30M
(+4.91%)
29M
(-5.49%)
31M
(+2.00%)
30M
(-20.46%)
38M
(+11.40%)
34M
(-21.67%)
43M
(+9.69%)
39M
(-0.25%)
40M
(-61.93%)
104M
(+209.88%)
34M----
Operating Expenses
Selling General And Administrative
13M
(-21.46%)
16M
(+9.16%)
15M
(-4.72%)
15M
(+14.26%)
14M
(-2.52%)
14M
(-16.39%)
17M
(+36.85%)
12M
(-19.46%)
15M
(-71.47%)
53M
(+292.49%)
13M----
Operating Expenses
13M
(-21.46%)
16M
(+9.16%)
15M
(-4.72%)
15M
(+14.26%)
14M
(-53.58%)
29M
(-0.85%)
29M
(+142.37%)
12M
(-19.46%)
15M
(-71.24%)
52M
(+288.43%)
13M
(+3034.88%)
430K
(+16.22%)
370K--
Depreciation And Amortization
670K
(-35.58%)
1.04M
(+131.11%)
450K
(-19.64%)
560K
(-11.11%)
630K
(-56.85%)
1.46M
(+94.67%)
750K
(+31.58%)
570K
(-44.12%)
1.02M
(-90.14%)
10M
(+444.74%)
1.90M----
Operating Income
Operating Income
18M
(+37.90%)
13M
(-19.08%)
16M
(+9.14%)
15M
(-39.88%)
24M
(+412.71%)
4.72M
(-65.87%)
14M
(-49.32%)
27M
(+11.57%)
24M
(-52.50%)
52M
(+157.24%)
20M-470.00K
(+20.51%)
-390.00K--
Ebit
18M
(+37.90%)
13M
(-19.08%)
16M
(+9.14%)
15M
(-39.88%)
24M
(+412.71%)
4.72M
(-65.87%)
14M
(-49.32%)
27M
(+11.57%)
24M
(-52.50%)
52M
(+157.24%)
20M-470.00K
(+20.51%)
-390.00K--
EBITDA
18M
(+32.40%)
14M
(-14.94%)
16M
(+8.00%)
15M
(-39.11%)
25M
(+301.78%)
6.18M
(-57.61%)
15M
(-47.67%)
28M
(+9.34%)
25M
(-57.36%)
60M
(+172.58%)
22M
(+5988.89%)
360K
(-59.09%)
880K--
Other Income / Expenses
Interest Income
120K-120K
(+500.00%)
20K
(-66.67%)
60K-20.00K10K
(0.00%)
10K
(-50.00%)
20K
(-75.00%)
80K
(+700.00%)
10K----
Interest Expense
110K
(+120.00%)
50K
(+25.00%)
40K
(-20.00%)
50K-10K
(0.00%)
10K
(0.00%)
10K-40K-----
Net Interest Income
10K-50.00K80K-20.00K50K-30.00K--10K
(-75.00%)
40K
(+300.00%)
10K----
Other Non Operating Income
1.14M
(-92.18%)
15M
(+454.37%)
2.63M-1.01M7.25M
(+130.16%)
3.15M-730.00K
(+265.00%)
-200.00K2.74M
(-6.16%)
2.92M
(+178.10%)
1.05M----
Net Income
Income Before Tax
19M
(+1.56%)
19M
(+0.32%)
19M
(+36.71%)
14M
(-56.95%)
31M
(+418.98%)
6.06M
(-53.78%)
13M
(-51.61%)
27M
(-0.40%)
27M
(-46.95%)
51M
(+143.33%)
21M
(+5752.78%)
360K
(-59.09%)
880K--
Income Tax Expense
7.53M
(+75.52%)
4.29M
(-24.34%)
5.67M
(-48.92%)
11M
(+11.45%)
9.96M-490.00K10M
(+20.40%)
8.53M
(+0.95%)
8.45M
(-60.84%)
22M
(+65.87%)
13M
(+7552.94%)
170K
(-34.62%)
260K--
Net Income From Continuing Operations
11M
(-20.35%)
14M
(+10.76%)
13M
(+421.14%)
2.46M
(-88.56%)
22M
(+228.75%)
6.54M
(+131.10%)
2.83M
(-84.69%)
18M
(-1.49%)
19M
(-37.88%)
30M
(+261.24%)
8.36M
(+4080.00%)
200K
(-67.21%)
610K--
Net Income
11M
(-20.35%)
14M
(+10.76%)
13M
(+421.14%)
2.46M
(-88.56%)
22M
(+228.75%)
6.54M
(+131.10%)
2.83M
(-84.69%)
18M
(-1.49%)
19M
(-37.88%)
30M
(+261.24%)
8.36M
(+4080.00%)
200K
(-67.21%)
610K--
Comprehensive Income Net Of Tax
7.06M
(-85.25%)
48M
(+693.86%)
6.03M
(-44.58%)
11M
(-65.28%)
31M
(+4.43%)
30M
(+28.03%)
23M
(+147.00%)
9.49M
(+9.71%)
8.65M
(-67.54%)
27M
(+266.57%)
7.27M----